Search Results for: CAR-T cancer

BBC report hails success of (Israeli) cancer treatment

According to the BBC, the CAR-T cancer therapy, (invented by Professor Zelig Eshhar of Israel’s Weizmann Institute) is curing 40% of UK lymphoma patients who were otherwise untreatable and terminal.  Amazing case stories – but doesn’t mention Israel of course! … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Growing cells to kill cancer

Israel’s Sheba hospital is partnering with Switzerland’s Lonza Group to fast-track production of the CAR-T cancer immunotherapy invented by Israeli scientists. Sheba is the first hospital to trial and refine Lonza’s Cocoon manufacturing platform for growing cells to treat hundreds … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Breakthrough cancer treatment available to Israelis

The Israeli-developed CAR-T cancer treatment is one of NIS 460 million worth of new treatments added to Israel’s 2019 Health Basket. CAR-T has over 80% success rate, even in terminal cases. The new treatments will benefit an estimated 70,000 Israelis. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Leukemia treatment extends to solid tumors

Tel Aviv University scientists have engineered the successful Israel-invented CAR-T cell therapy (see here) to also treat other cancers. They discovered a subset of immune system T cells (known as CD4+ T cells) will attract antibodies on solid tumors and … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Israeli leukemia treatment approved for UK children

The breakthrough CAR-T personalized leukemia therapy devised by Professor Zelig Eshhar of Israel’s Weizmann Institute (see here) is now available in the UK.  The National Health Service will fund Kymriah – the CAR-T treatment commercialized by Novartis. https://www.telegraph.co.uk/news/2018/09/04/nhs-fund-game-changing-personalised-cancer-drug/

Posted in Israel's Medical Achievements | Leave a comment

Lymphoma treatment approved

I reported previously (3rd Sep) on the US takeover of Israeli biotech Kite for $12 billion. The US FDA has now approved Kite’s Yescarta treatment for adults with relapsed or refractory large B-cell lymphoma. The treatment uses Israeli-developed CAR-T therapy … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Israeli-founded biotech exits for $11.9 billion

US giant Gilead has just bought Kite (a biotech founded by Israel’s Arie Belldegrun) for $11.9 billion.  Kite’s CAR-T technology was developed by Weizmann Institute’s Professor Zelig Eshhar. A patient’s own immune system T-cells are genetically engineered to attack tumors. … Continue reading

Posted in Economy & Business | Leave a comment